Literature DB >> 24903005

A comprehensive analysis of middle-European molecular sensitization profiles to pollen allergens.

Petr Panzner1, Martina Vachová, Petra Vítovcová, Petra Brodská, Tomáš Vlas.   

Abstract

Molecular diagnosis of allergy and microarray technology have opened a completely new avenue of insight into sensitization profiles from both the clinical and the epidemiological point of view. We used this innovative tool in the description of sensitization patterns in pollen-sensitized patients in Middle Europe. Immunoglobulin E detection using 112 different allergenic molecules was carried out employing the ImmunoCAP ISAC microarray system. Sera from 826 patients sensitized to at least one pollen-derived molecule were subjected to analysis. The highest observed sensitization rate was 81.0% to grass-specific molecules (the most frequent being Phl p 1; 69.6%). The second most frequent sensitization was 54.8% to Betulaceae-specific molecules (Bet v 1; 54.2%). Together, grasses and Betulaceae components (and their cosensitizations with other components) comprised the vast majority of pollen sensitizations. Unexpectedly frequently observed sensitizations were those to Cupressaceae-specific molecules (14.1%), Oleaceae-specific molecules (10.8%), and the plane tree-derived molecule Pla a 2 (15.5%). The sensitization rates for all other molecules were within the expected range (Art v 1, 13.6%; Pla l 1, 9.6%; Che a 1, 8.4%; Par j 2, 0.9%; Amb a 1, 0.8%, and Sal k 1, 0.5%). Cross-reacting molecule sensitization rates were found to be 12.4% for profilins, 5.0% for polcalcins, and 6.4% for lipid transfer proteins. Molecular diagnosis of allergy gives a more precise and comprehensive insight into pollen sensitization patterns than extract-based testing, allowing a better understanding of the sensitization process and regional differences. The data presented here may help to improve the diagnostic and allergen-specific treatment procedures in the respective region.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24903005     DOI: 10.1159/000362760

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  13 in total

1.  Molecular evolution of hypoallergenic hybrid proteins for vaccination against grass pollen allergy.

Authors:  Birgit Linhart; Margarete Focke-Tejkl; Milena Weber; Meena Narayanan; Angela Neubauer; Hannes Mayrhofer; Katharina Blatt; Christian Lupinek; Peter Valent; Rudolf Valenta
Journal:  J Immunol       Date:  2015-03-18       Impact factor: 5.422

Review 2.  Recombinant Allergens in Structural Biology, Diagnosis, and Immunotherapy.

Authors:  Angelika Tscheppe; Heimo Breiteneder
Journal:  Int Arch Allergy Immunol       Date:  2017-05-04       Impact factor: 2.749

3.  Early childhood IgE reactivity to pathogenesis-related class 10 proteins predicts allergic rhinitis in adolescence.

Authors:  Marit Westman; Christian Lupinek; Jean Bousquet; Niklas Andersson; Sandra Pahr; Alexandra Baar; Anna Bergström; Mats Holmström; Pär Stjärne; Karin C Lødrup Carlsen; Kaj-Håkon Carlsen; Josep M Antó; Rudolf Valenta; Marianne van Hage; Magnus Wickman
Journal:  J Allergy Clin Immunol       Date:  2014-12-18       Impact factor: 10.793

Review 4.  Tree pollen allergens-an update from a molecular perspective.

Authors:  C Asam; H Hofer; M Wolf; L Aglas; M Wallner
Journal:  Allergy       Date:  2015-08-06       Impact factor: 13.146

5.  Debates in allergy medicine: Molecular allergy diagnosis with ISAC will replace screenings by skin prick test in the future.

Authors:  E Jensen-Jarolim; A N Jensen; G W Canonica
Journal:  World Allergy Organ J       Date:  2017-09-19       Impact factor: 4.084

6.  Cross-sectional study on sensitization to mite and cockroach allergen components in allergy patients in the Central European region.

Authors:  Petr Panzner; Martina Vachová; Tomáš Vlas; Petra Vítovcová; Petra Brodská; Marek Malý
Journal:  Clin Transl Allergy       Date:  2018-06-04       Impact factor: 5.871

7.  Fusion proteins consisting of Bet v 1 and Phl p 5 form IgE-reactive aggregates with reduced allergenic activity.

Authors:  N Najafi; G Hofer; P Gattinger; D Smiljkovic; K Blatt; R Selb; A Stoecklinger; W Keller; P Valent; V Niederberger; J Thalhamer; R Valenta; S Flicker
Journal:  Sci Rep       Date:  2019-03-08       Impact factor: 4.379

Review 8.  Pollen Allergens for Molecular Diagnosis.

Authors:  Isabel Pablos; Sabrina Wildner; Claudia Asam; Michael Wallner; Gabriele Gadermaier
Journal:  Curr Allergy Asthma Rep       Date:  2016-04       Impact factor: 4.806

9.  An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trial.

Authors:  A M Chaker; B Al-Kadah; U Luther; U Neumann; M Wagenmann
Journal:  Clin Transl Allergy       Date:  2016-02-02       Impact factor: 5.871

10.  In vivo Induction of Functional Inhibitory IgG Antibodies by a Hypoallergenic Bet v 1 Variant.

Authors:  Lorenz Aglas; Athanasios Bethanis; Paulina Chrusciel; Frank Stolz; Melanie Gruen; Ulla-Marjut Jaakkola; Laurian Jongejan; Emrah Yatkin; Ronald Van Ree
Journal:  Front Immunol       Date:  2020-09-03       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.